No insider purchase over the last 90 days. The latest, by 이슬기, was filed 11 Jun 2026.
Who traded when
BuySale+5 other insiders
Since the insiders bought
- -53.1%Entry ₩87,700 · Close 22 Oct 2026 ₩41,100
- -53.1%Entry ₩87,700 · Close 22 Oct 2026 ₩41,100
- -53.1%Entry ₩87,700 · Close 22 Oct 2026 ₩41,100
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- Other0DART
- 23,382 sharesKRXDART:20260611000427Canonical exit: 9 Sept 2026 (T+90)
- 2,400 sharesShareKRXDART:20260609000215Canonical exit: 7 Sept 2026 (T+90)
- 56,000 sharesShareKRXDART:20260609000220Canonical exit: 7 Sept 2026 (T+90)
- 38,000 sharesShareKRXDART:20260609000223Canonical exit: 7 Sept 2026 (T+90)
- 4,000 shares@ ₩94,222.9611100.0% of flowShareKRXDART:20260515002416
- ●Executives0DART
- 40,500 sharesShareKRXDART:20251205000179Canonical exit: 5 Mar 2026 (T+90)
- 7,500 sharesShareKRXDART:20251205000185Canonical exit: 5 Mar 2026 (T+90)
- 187,500 sharesShareKRXDART:20251205000176Canonical exit: 5 Mar 2026 (T+90)
- 4,500 sharesShareKRXDART:20251205000182Canonical exit: 5 Mar 2026 (T+90)
- 75,000 sharesShareKRXDART:20251205000170Canonical exit: 5 Mar 2026 (T+90)
- 4,241,643 sharesShareKRXDART:20251205000164Canonical exit: 5 Mar 2026 (T+90)
- 59,070 sharesKRXDART:20250709000131Canonical exit: 11 Sept 2025 (T+90)
- 350,847 sharesKRXDART:20250610000353
- 547,012 sharesKRXDART:20250307000964
- 370,847 sharesKRXDART:20250210000482
- 308,473 sharesKRXDART:20250109000306
- 52,369 sharesShareKRXDART:20241223000251
- 1,400 sharesShareKRXDART:20241210000052Canonical exit: 10 Mar 2025 (T+90)
- 1,500 sharesShareKRXDART:20241210000050Canonical exit: 10 Mar 2025 (T+90)
- 7,000 sharesShareKRXDART:20241210000046Canonical exit: 10 Mar 2025 (T+90)
- 500 sharesShareKRXDART:20241210000051Canonical exit: 10 Mar 2025 (T+90)
- 6,000 sharesShareKRXDART:20241210000048Canonical exit: 10 Mar 2025 (T+90)
25 of 37 declarations
About D&D Pharmatech Inc.
D&D Pharmatech Inc. (디앤디파마텍) has a short history: 35 filings published between May 3, 2024 and June 11, 2026, from 13 filers, with 18 in 2024, 11 in 2025 and 6 in 2026. There are 18 purchases and 10 sales, 64% purchases, with no recorded amount; 7 filings are of another kind, which leaves the record short on euro figures.
On the buying side, 신재희 (이사) made 9 filings, 4 of them purchases, and 박평아 (상무) and 임성묵 (전무) made 3 each, all purchases. On the selling side, 스마일게이트인베스트먼트, filed as 대량보유자, made 6 filings, all sales, and OctaveLifeSciences,L.P. made 3, also all sales. On December 5, 2025, 6 filers bought on the same day.
Read moreShow less
Insiders own 20.1% of this health care company, which has a market value of KRW 2.0 trillion. The final 12 months bring 12 filings, 10 purchases and no sale, with a median gap of 5 days before publication.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
